Inventor
ZHANG YINSHENG
CN10 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG YINSHENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
9 patentsUS11597716B2Mar 7, 2023
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD5 citations72
US12240811B2Mar 4, 2025
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition and uses thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US12116356B2Oct 15, 2024
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US12378192B2Aug 5, 2025
Crystalline form of capsid protein assembly inhibitor containing N hetero five-membered ring, and application thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations59
US10717753B2Jul 21, 2020
Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1 citations59
US12384745B2Aug 12, 2025
Crystal form of five-membered n heterocyclic compound, and application thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations56
US11891405B2Feb 6, 2024
Furo[3,4-b]pyrrole-containing BTK inhibitor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations45
US12565511B2Mar 3, 2026
SOS1 inhibitor containing phosphorus
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations41
US10766912B2Sep 8, 2020
Silicon-containing compound for resistance to hepatitis C virus infection
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations34